Akebia Therapeutics IncNASDAQ:AKBA
- LAST PRICE1.3600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.3400/ 3
- Ask / Lots1.3900/ 1
- Open / Previous Close0.0000 / 1.3600
- Day Range---
- 52 Week Range
- Volume5,167
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AKBA |
|---|---|---|
| 09:32 ET | 69773 | 1.365 |
| 09:34 ET | 27516 | 1.35 |
| 09:36 ET | 28963 | 1.35 |
| 09:38 ET | 9343 | 1.35 |
| 09:39 ET | 45264 | 1.35 |
| 09:41 ET | 8485 | 1.355 |
| 09:43 ET | 16315 | 1.35 |
| 09:45 ET | 21100 | 1.36 |
| 09:48 ET | 600 | 1.36 |
| 09:50 ET | 11479 | 1.355 |
| 09:52 ET | 28374 | 1.3595 |
| 09:54 ET | 18853 | 1.3505 |
| 09:56 ET | 28736 | 1.35 |
| 09:57 ET | 1230 | 1.355 |
| 09:59 ET | 7655 | 1.3588 |
| 10:01 ET | 13498 | 1.35 |
| 10:03 ET | 800 | 1.355 |
| 10:06 ET | 6339 | 1.3527 |
| 10:08 ET | 13900 | 1.355 |
| 10:10 ET | 21990 | 1.365 |
| 10:12 ET | 1450 | 1.364 |
| 10:14 ET | 12768 | 1.36 |
| 10:15 ET | 6139 | 1.365 |
| 10:17 ET | 500 | 1.36 |
| 10:19 ET | 4858 | 1.36 |
| 10:21 ET | 300 | 1.35 |
| 10:24 ET | 40407 | 1.35 |
| 10:26 ET | 4091 | 1.3474 |
| 10:28 ET | 6038 | 1.34 |
| 10:30 ET | 3405 | 1.3409 |
| 10:32 ET | 3101 | 1.345 |
| 10:33 ET | 3174 | 1.34 |
| 10:35 ET | 2050 | 1.345 |
| 10:37 ET | 1858 | 1.3403 |
| 10:39 ET | 20328 | 1.35 |
| 10:42 ET | 26705 | 1.35 |
| 10:44 ET | 15500 | 1.3475 |
| 10:46 ET | 1113 | 1.345 |
| 10:48 ET | 1050 | 1.345 |
| 10:50 ET | 1715 | 1.345 |
| 10:51 ET | 39200 | 1.3486 |
| 10:53 ET | 1877 | 1.3421 |
| 10:55 ET | 800 | 1.35 |
| 11:00 ET | 3579 | 1.35 |
| 11:02 ET | 8258 | 1.345 |
| 11:04 ET | 1193 | 1.35 |
| 11:06 ET | 100 | 1.345 |
| 11:08 ET | 471 | 1.345 |
| 11:09 ET | 1084 | 1.345 |
| 11:11 ET | 5600 | 1.345 |
| 11:13 ET | 500 | 1.345 |
| 11:15 ET | 2464 | 1.345 |
| 11:18 ET | 51562 | 1.345 |
| 11:20 ET | 3817 | 1.345 |
| 11:22 ET | 3009 | 1.345 |
| 11:24 ET | 700 | 1.345 |
| 11:26 ET | 9800 | 1.345 |
| 11:27 ET | 2102 | 1.3401 |
| 11:29 ET | 1100 | 1.345 |
| 11:31 ET | 600 | 1.345 |
| 11:33 ET | 3982 | 1.345 |
| 11:36 ET | 1300 | 1.345 |
| 11:38 ET | 1400 | 1.345 |
| 11:40 ET | 5800 | 1.345 |
| 11:42 ET | 3500 | 1.345 |
| 11:44 ET | 14725 | 1.345 |
| 11:45 ET | 826 | 1.345 |
| 11:47 ET | 1200 | 1.345 |
| 11:49 ET | 1400 | 1.35 |
| 11:51 ET | 10200 | 1.3424 |
| 11:54 ET | 5128 | 1.35 |
| 11:56 ET | 500 | 1.345 |
| 11:58 ET | 50575 | 1.345 |
| 12:00 ET | 2300 | 1.345 |
| 12:02 ET | 69970 | 1.375 |
| 12:03 ET | 2659 | 1.38 |
| 12:05 ET | 58005 | 1.385 |
| 12:07 ET | 7030 | 1.385 |
| 12:09 ET | 7300 | 1.385 |
| 12:12 ET | 10200 | 1.387 |
| 12:14 ET | 3945 | 1.39 |
| 12:16 ET | 35761 | 1.3939 |
| 12:18 ET | 2856 | 1.395 |
| 12:20 ET | 14360 | 1.395 |
| 12:21 ET | 3120 | 1.394 |
| 12:23 ET | 2150 | 1.395 |
| 12:25 ET | 273 | 1.3905 |
| 12:27 ET | 5340 | 1.395 |
| 12:30 ET | 300 | 1.395 |
| 12:32 ET | 11054 | 1.3901 |
| 12:34 ET | 1856 | 1.395 |
| 12:36 ET | 3857 | 1.395 |
| 12:38 ET | 4658 | 1.395 |
| 12:39 ET | 1300 | 1.395 |
| 12:41 ET | 49064 | 1.3883 |
| 12:43 ET | 20479 | 1.37 |
| 12:45 ET | 34858 | 1.365 |
| 12:48 ET | 3100 | 1.365 |
| 12:50 ET | 3544 | 1.365 |
| 12:52 ET | 1300 | 1.365 |
| 12:54 ET | 1200 | 1.365 |
| 12:56 ET | 1906 | 1.365 |
| 12:57 ET | 600 | 1.365 |
| 12:59 ET | 500 | 1.365 |
| 01:01 ET | 900 | 1.365 |
| 01:03 ET | 400 | 1.365 |
| 01:06 ET | 1213 | 1.365 |
| 01:08 ET | 500 | 1.365 |
| 01:10 ET | 400 | 1.365 |
| 01:12 ET | 702 | 1.365 |
| 01:14 ET | 500 | 1.365 |
| 01:15 ET | 547 | 1.3652 |
| 01:17 ET | 543 | 1.37 |
| 01:19 ET | 300 | 1.365 |
| 01:21 ET | 5400 | 1.365 |
| 01:24 ET | 500 | 1.365 |
| 01:26 ET | 9712 | 1.3619 |
| 01:28 ET | 30324 | 1.365 |
| 01:30 ET | 2003 | 1.365 |
| 01:32 ET | 4185 | 1.365 |
| 01:35 ET | 1000 | 1.3686 |
| 01:37 ET | 30540 | 1.37 |
| 01:39 ET | 2725 | 1.365 |
| 01:42 ET | 1466 | 1.37 |
| 01:44 ET | 4835 | 1.365 |
| 01:46 ET | 2802 | 1.365 |
| 01:48 ET | 300 | 1.365 |
| 01:50 ET | 6559 | 1.37 |
| 01:51 ET | 47654 | 1.385 |
| 01:53 ET | 25293 | 1.395 |
| 01:55 ET | 4522 | 1.395 |
| 01:57 ET | 7697 | 1.39 |
| 02:00 ET | 6029 | 1.394 |
| 02:02 ET | 2200 | 1.395 |
| 02:04 ET | 16314 | 1.3901 |
| 02:06 ET | 6400 | 1.39 |
| 02:08 ET | 3800 | 1.395 |
| 02:09 ET | 1325 | 1.39 |
| 02:11 ET | 1500 | 1.395 |
| 02:13 ET | 19600 | 1.3942 |
| 02:15 ET | 1250 | 1.395 |
| 02:18 ET | 8600 | 1.395 |
| 02:20 ET | 6126 | 1.39 |
| 02:22 ET | 5799 | 1.395 |
| 02:24 ET | 18634 | 1.3915 |
| 02:26 ET | 14065 | 1.395 |
| 02:27 ET | 2643 | 1.395 |
| 02:29 ET | 1700 | 1.395 |
| 02:31 ET | 3817 | 1.39 |
| 02:33 ET | 850 | 1.395 |
| 02:36 ET | 3302 | 1.395 |
| 02:38 ET | 2496 | 1.39 |
| 02:40 ET | 34550 | 1.385 |
| 02:42 ET | 16003 | 1.3799 |
| 02:44 ET | 3163 | 1.375 |
| 02:45 ET | 4997 | 1.375 |
| 02:47 ET | 1400 | 1.375 |
| 02:49 ET | 13636 | 1.375 |
| 02:51 ET | 1400 | 1.375 |
| 02:54 ET | 5400 | 1.3718 |
| 02:56 ET | 794 | 1.375 |
| 02:58 ET | 1073 | 1.375 |
| 03:00 ET | 5519 | 1.37 |
| 03:02 ET | 1380 | 1.3724 |
| 03:03 ET | 1429 | 1.375 |
| 03:05 ET | 912 | 1.375 |
| 03:07 ET | 801 | 1.375 |
| 03:09 ET | 1216 | 1.37 |
| 03:12 ET | 2155 | 1.375 |
| 03:14 ET | 600 | 1.375 |
| 03:16 ET | 1200 | 1.37 |
| 03:18 ET | 930 | 1.3702 |
| 03:20 ET | 15600 | 1.375 |
| 03:21 ET | 2402 | 1.37 |
| 03:23 ET | 2630 | 1.37 |
| 03:25 ET | 33931 | 1.36 |
| 03:27 ET | 2297 | 1.36 |
| 03:30 ET | 2153 | 1.36 |
| 03:32 ET | 2462 | 1.36 |
| 03:34 ET | 10917 | 1.36 |
| 03:36 ET | 3050 | 1.36 |
| 03:38 ET | 2100 | 1.36 |
| 03:39 ET | 1500 | 1.365 |
| 03:41 ET | 2344 | 1.365 |
| 03:43 ET | 1613 | 1.365 |
| 03:45 ET | 2300 | 1.365 |
| 03:48 ET | 26094 | 1.365 |
| 03:50 ET | 4200 | 1.365 |
| 03:52 ET | 14415 | 1.365 |
| 03:54 ET | 6794 | 1.365 |
| 03:56 ET | 12413 | 1.365 |
| 03:57 ET | 23561 | 1.365 |
| 03:59 ET | 33674 | 1.36 |
Apr 2, 2024
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Tuesday Apr 02, 2024 by Dow Jones
4:05PM ET on Tuesday Apr 02, 2024 by Dow Jones
Apr 1, 2024
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?, from 9:31AM ET on Monday Apr 01, 2024 by Dow Jones
9:31AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 28, 2024
DJ Akebia Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 12:29PM ET on Thursday Mar 28, 2024 by Dow Jones
12:29PM ET on Thursday Mar 28, 2024 by Dow JonesThinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?, from 9:31AM ET on Thursday Mar 28, 2024 by Dow Jones
9:31AM ET on Thursday Mar 28, 2024 by Dow JonesDJ Akebia Shares Rally Premarket After FDA Approves Vafseo, from 6:15AM ET on Thursday Mar 28, 2024 by Dow Jones
6:15AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Akebia Therapeutics Inc | 284.7M | -4.9x | --- |
Vanda Pharmaceuticals Inc | 276.2M | 109.5x | -37.98% |
Adaptive Biotechnologies Corp | 364.2M | -1.6x | --- |
Sutro Biopharma Inc | 284.6M | -2.1x | --- |
Anika Therapeutics Inc | 379.9M | -4.6x | --- |
Puma Biotechnology Inc | 249.2M | 11.5x | --- |
Company Information
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company. The Company is focused on developing and commercializing therapeutics. The Company’s portfolio and hypoxia-inducible factor (HIF)-based pipeline includes Auryxia (ferric citrate), Vafseo (vadadustat), AKB-9090 and AKB-10108. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the United States for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Vafseo (vadadustat) is a HIF prolyl hydroxylase (HIF-PH), inhibitor, approved in 36 countries as a treatment for anemia due to chronic kidney disease (CKD). It utilizes third parties for the commercial distribution of Auryxia, including wholesale distributors and certain specialty pharmacy providers.
Contact Information
- Headquarters
- 245 First StreetCAMBRIDGE, MA, United States 02142
- Phone
- 617-871-2098
- Fax
- 617-871-2099
Executives
- Independent Chairman of the Board
- Adrian Adams
- President, Chief Executive Officer, Interim Principal Financial Officer, Director
- John Butler
- Chief Operating Officer, Senior Vice President
- Michel Dahan
- Senior Vice President, Chief Legal Officer, Corporate Secretary
- Nicole Hadas
- Senior Vice President - Research and Development, Chief Medical Officer
- Steven Burke
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $284.7M |
|---|---|
Revenue (TTM) | $194.6M |
Shares Outstanding | 209.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.92 |
EPS | $-0.28 |
Book Value | $-0.16 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -24.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
